Cumulative Radiation Dose From CT in Young People Linked to Malignancy Risk
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 28, 2023 -- Cumulative radiation dose to the bone marrow as a result of computed tomography (CT) examinations in individuals aged younger than 22 years is associated with an increased risk for subsequent hematological malignancies, according to a study published online Nov. 9 in Nature Medicine.
Magda Bosch de Basea Gomez, Ph.D., from the Barcelona Institute for Global Health in Spain, and colleagues followed a multinational cohort of 948,174 individuals who underwent CT examinations before age 22 years in nine European countries. On the basis of body part scanned, patient characteristics, time period, and inferred CT technical parameters, radiation doses to the active bone marrow were estimated.
The researchers found an association between cumulative dose and risk for all hematological malignancies, with an excess relative risk of 1.96 (95 percent confidence interval, 1.10 to 3.12) per 100 mGy. For lymphoid and myeloid malignancies, similar estimates were obtained. For every 10,000 children examined today (mean dose, 8 mGy), in the subsequent 12 years, one to two persons are expected to develop a hematological malignancy attributable to radiation exposure.
"The findings highlight the need for raising awareness in the medical community and continued strict application of radiological protection measures in medical settings through justification and optimization of radiological procedures, particularly in pediatric populations," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-29 00:32
Read more
- Single Peoples' Personalities Differ from Partnered Peoples'
- Psychedelics May Boost Mental Health of People with Cancer in Recovery
- Life Expectancy Increased From 2022 to 2023, Reaching 78.4 Years
- Newer Drug Could Be Advance Against Tough-to-Treat Breast Cancers
- Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
- FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions